Safety Rates Drug Report: EFAVIRENZ Foetal exposure during pregnancy adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: EFAVIRENZ Injury: Foetal exposure during pregnancy Quarter: 2016Q3

|< 1/2 << Previous Page Page 3

Total Records: 46 Number of Pages: 3

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127044881	EFAVIRENZ	Foetal exposure during pregnancy	MERCK	1.00 DY	M	0	20160831	US
127428941	EFAVIRENZ	Foetal exposure during pregnancy	MYLAN	0.00		0	20160914	MZ
127676692	EFAVIRENZ	Foetal exposure during pregnancy	BRISTOL MYERS SQUIBB	0.00	F	1 KG	20160926	MZ
417522510	EFAVIRENZ	Foetal exposure during pregnancy	BRISTOL MYERS SQUIBB	1.00 DY	M	4 KG	20160825	CH
635651610	EFAVIRENZ	Foetal exposure during pregnancy	BRISTOL MYERS SQUIBB	0.00 YR	F	1 KG	20160825	US
643121811	EFAVIRENZ	Foetal exposure during pregnancy	BRISTOL MYERS SQUIBB	0.00	F	3 KG	20160902	ZA

|< 1/2 << Previous Page Page 3

Total Records: 46 Number of Pages: 3

Execution Time: 0.0082888603210449 seconds (ucode:5259884). Developed by: James D. Barger